Figure 3From: Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastasesKaplan-Meier analysis of overall survival after SRT/SRS treatment of a brainstem metastasis. Median overall survival was found to be 3 months.Back to article page